Expression of TGFß1 and its receptors is associated with biological features of ovarian cancer and sensitivity to paclitaxel/carboplatin Ovarian Cancer and Us OVARIAN CANCER and US Ovarian Cancer and Us

Blog Archives: Nov 2004 - present

#ovariancancers



Special items: Ovarian Cancer and Us blog best viewed in Firefox

Search This Blog

Friday, January 21, 2011

Expression of TGFß1 and its receptors is associated with biological features of ovarian cancer and sensitivity to paclitaxel/carboplatin



Abstract ....... It is suggested that TGFß1 mRNA expression is an indicator of tumor sensitivity to standard therapy with PTX (Taxol) and CBDCA (Carboplatin), that it can identify biologically aggressive and highly malignant tumors and that it can predict the prognosis of patients with ovarian cancer."

0 comments :

Post a Comment

Your comments?

Note: Only a member of this blog may post a comment.